Guidance: SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01

Public Health England

December 23
14:12 2020


Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 60 have been considered to date, approximately 30% of which have progressed to extended evaluation on clinical samples at Phase 3.

Published 23 December 2020

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: